Kui Huang, PhD

Pfizer Inc

Poster(s):

• (264) A Non-Interventional Study Using Multiple Data Sources to Evaluate Potential Sight Threatening Events and Severe Visual Loss Among Patients Exposed to Crizotinib
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (AG) A Population-Based Study on The Prevalence of Diagnosed Primary Immune Thrombocytopenia in the United States, 2016-2021
  Sunday, August 28, 2022

  8:00 AM – 6:00 PM CEST

• (AM) Natural History of Wilson's Disease in the United States Using Optum® Electronic Health Records
  Sunday, August 28, 2022

  8:00 AM – 6:00 PM CEST

• (23) Prevalence and Clinical Burden of Genetic Dilated Cardiomyopathy in The United States: Results from The Optum® Electronic Health Records Database
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (142) Validation of Safety Outcomes in Routinely Collected Data: Lessons Learned from a Multinational Post-Approval Safety Study
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST